Search

Search Results

• Clinical Features and Treatment Outcomes of HIV-Associated Diffuse Large B-Cell Lymphoma

  Anastasia Borisovna Galitsyna, N.A. Falaleeva, O.V. Levkovskiy, V.A. Shuvaev, A.Yu. Terekhova, M.G. Syadrin, E.A. Norot, A.M. Chelmakov, S.A. Ivanov, A.D. Kaprin

  49-58

  01.01.2026

• Bruton Tyrosine Kinase Inhibitors for the Treatment of Mantle Cell Lymphoma: A Literature Review and Our Own Experience

  Ulyana Gordeevna Koshkina, A.A. Semenova, M.Yu. Kichigina, D.N. Tupitsyna, V.O. Shpirko, A.I. Cherencova, S.F. Ramazanova, N.O. Zemlyakov, I.Z. Zavodnova, A.V. Arakelyan, G.D. Petrova, O.Yu. Baranova, G.S. Tumyan

  59-69

  01.01.2026

• Characteristic Features of COVID-19 and Opportunities for Its Prevention in Multiple Myeloma Patients

  Darya Aleksandrovna Chebykina, I.I. Krobinets

  96-103

  01.01.2026

• Teclistamab for Multiple Myeloma Therapy: A Literature Review and the First Clinical Use in Russia

  Anastasiya Aleksandrovna Semenova, A.S. Luchinin, A.S. Subbotin, G.S. Tumyan, A.V. Arakelyan, A.I. Cherencova, S.S. Kamyshanov

  388-394

  01.10.2025

• Effectiveness of the Initial Escalation of Immunochemotherapy in Patients with High Risk MALT-Lymphoma: Pilot Study Results

  Anna Konstantinovna Smol’yaninova, N.G. Gabeeva, S.A. Tatarnikova, A.V. Belyaeva, A.M. Kovrigina, E.G. Gemdzhyan, E.E. Zvonkov

  338-348

  01.07.2025

• Risk Factors for Relapses of Perianal Infectious Complications in Patients with Hematological Malignancies: Results of a Single-Center Prospective Trial

  Svetlana Vitalevna Shtyrkova, K.I. Danishyan, E.N. Parovichnikova

  204-212

  01.04.2024

• Dynamics of SARS-CoV-2 RNA Detection in Patients and Employees of the National Research Center for Hematology During the First Two Years of the Novel COVID-19 Pandemic

  Oksana Gazimagomedovna Starkova, D.S. Tikhomirov, A.Yu. Krylova, I.O. Snezhko, E.N. Ovchinnikova, O.A. Aleshina, T.A. Tupoleva, T.V. Gaponova

  186-191

  03.03.2023

• Experience with the Use of B-RAF Inhibitor Vemurafenib in the Treatment of Hairy Cell Leukemia

  L.S. Al-Radi, Svetlana Yurevna Smirnova, T.N. Moiseeva, I.S. Piskunova, L.V. Plastinina, D.V. Novikova, E.G. Gemdzhian, G.M. Galstyan

  349-355

  01.10.2022

• Azacitidine/Venetoclax Combination as First-Line Therapy in Elderly Patients with Acute Myeloid Leukemias: A First Step

  M.A. Granatkin, Evgenii Aleksandrovich Nikitin, E.S. Mikhailov, V.A. Doronin, S.V. Minenko, M.M. Okuneva, N.V. Degtyareva, M.E. Pochtar, S.A. Lugovskaya, Yu.N. Kobzev, O.Yu. Vinogradova, V.V. Ptushkin

  282-288

  01.07.2022

• Infectious Complications in Multiple Myeloma under Current Epidemiological Conditions: A Literature Review

  I.L. Davydkin, Elizaveta Vladimirovna Mordvinova, T.P. Kuzmina

  386-390

  01.07.2021

• Obesity as a Poor Prognostic Factor in Multiple Myeloma

  Evgenii Sergeevich Mikhailov, G.N. Salogub, S.S. Bessmeltsev

  315-320

  01.07.2021

• Gemtuzumab Ozogamicin in the Treatment of Critical Patients with Refractory Acute Myeloid Leukemia (3 Case Reports)

  Daniil Vladislavovich Zaitsev, L.L. Girshova, V.V. Ivanov, I.G. Budaeva, D.V. Motorin, R.Sh. Badaev, K.V. Bogdanov, Yu.V. Mirolyubova, T.S. Nikulina, K.A. Zagorodnikova, N.A. Zhukova, S.V. Efremova, T.V. Chitanava, Yu.A. Alekseeva, A.Y. Zaritskey

  67-74

  01.01.2020

• Risk Factors for Rehospitalizations after Allogeneic Hematopoietic Stem Cell Transplantation

  Mikhail Yur’evich Drokov, A.A. Dmitrova, L.A. Kuzmina, V.A. Vasil’eva, E.D. Mikhaltsova, O.M. Koroleva, E.V. Usikova, E.N. Parovichnikova, V.G. Savchenko

  89-94

  01.01.2020

• Role of Biochemical Inflammatory Markers in Patients with Chemotherapy-Induced Neutropenia

  Yuliya Nikolaevna Dubinina, V.O. Sarzhevskii, V.Ya. Melnichenko

  461-467

  01.10.2019

• Infectious Complications after Haploidentical Hematopoietic Stem Cells Transplantation in Patients with High-Risk Tumors of Hematopoietic and Lymphoid Tissues: A Single-Center Experience

  Yurii Sergeevich Osipov, S.S. Bessmeltsev, G.N. Salogub, V.V. Ivanov, E.S. Mikhailov, N.A. Zhukova, A.V. Chechetkin

  406-415

  01.10.2019

• Infectious Complications in Multiple Myeloma Patients Receiving Various Antitumor Regimens

  Anna Aleksandrovna Novikova, G.A. Klyasova, E.O. Gribanova, V.V. Ryzhko, T.A. Tupoleva, L.P. Mendeleeva, V.G. Savchenko

  231-239

  01.04.2019

• Intermediate Results of Prospective Observational Study: The 2-year Experience of Ibrutinib Therapy in Relapsed/Refractory Mantle Cell Lymphoma in Clinical Practice

  Vladimir Ivanovich Vorob’ev, V.A. Zherebtsova, E.I. Dubrovin, L.A. Bychenkova, Yu.B. Kochkareva, L.A. Mukha, V.L. Ivanova, N.K. Khuazheva, V.V. Ptushkin

  165-172

  01.04.2019

• Ibrutinib in the Treatment of Relapsed Chronic Lymphocytic Leukemia

  Elena Aleksandrovna Stadnik, N.S. Timofeeva, V.V. Strugov, A.Yu. Zaritskey

  42-49

  01.01.2018

• First-Line Therapy for Patients with Advanced Hodgkin’s Lymphoma: Efficacy and Toxicity of Intensive ЕАСОРР-14 Program (NN Blokhin National Medical Cancer Research Center Data)

  Elena Andreevna Demina, A.A. Leont’eva, G.S. Tumyan, Yu.E. Ryabukhina, O.P. Trofimova, N.V. Volkova, Yu.I. Pryamikova, V.M. Sotnikov, V.B. Larionova, E.G. Medvedovskaya, E.V. Paramonova, L.V. Manzyuk, N.A. Probatova, N.V. Kokosadze, E.A. Osmanov

  443-452

  01.10.2017

• The IVDG Regimen is the Possible Treatment of Choice as First Line Therapy For Hodgkin’s Lymphoma in Elderly Patients with Cardiovascular and Pulmonary Comorbidity

  Kamil’ Daniyalovich Kaplanov, T.Yu. Klitochenko, A.L. Shipaeva, M.N. Shirokova, I.V. Matveeva, N.B. Lavrishina

  358-365

  01.07.2017

• Diagnostic and Prognostic Value of Biochemical Markers of Infectious Complications of High-Dose Therapy with Autologous Hematopoietic Stem Cell Transplantation in Malignant Lymphoproliferative Diseases

  Vladislav Olegovich Sarzhevskii, Yu.N. Dubinina, V.Ya. Mel’nichenko

  113-119

  01.01.2017

• Factors Affecting Course and Outcome of Chronic Lymphocytic Leukemia: Data from Hematological Hospitals of Krasnoyarsk Region

  Varvara Ivanovna Bakhtina, I.V. Demko, A.N. Narkevich, D.S. Gushchin

  413-419

  01.10.2016

• Prevention of Acute Graft-Versus-Host Reaction after Allogeneic Unrelated Hematopoietic Stem Cell Transplantation: Comparison of Effectiveness of Treatment Regimens Based on Anti-Thymocyte Globulin and Cyclophosphamide

  Ol’ga Vladislavovna Pirogova, I.S. Moiseev, E.V. Babenko, O.A. Slesarchuk, O.V. Paina, S.N. Bondarenko, E.V. Morozova, A.L. Alyanskii, B.V. Afanas’ev

  391-397

  01.10.2016

• Diagnostic Value of C-Reactive Protein as Marker of Infections in Patients with De Novo Acute Myeloid Leukemias

  Lyudmila Nikolaevna Tarasova, S.G. Vladimirova, V.V. Cherepanova

  442-446

  01.10.2015

• Surgical Treatment of Perianal Infectious Complications in Hematologic Clinic

  Svetlana Vital’evna Shtyrkova, S.R. Karagyulyan, K.I. Danishyan, S.K. Kravchenko, V.V. Troitskaya, L.A. Kuz’mina

  337-342

  01.07.2015

• Taxonomic Structure and Antibiotic Resistance of Bloodstream Infection Pathogens in Oncohematological Patients

  Natal’ya Sergeevna Bagirova

  191-200

  01.04.2015

• Gastrointestinal Complications after High-Dose Chemotherapy and Autologous Bone Marrow Transplantation in Oncohematological Patients

  V.O. Sarzhevskiy, E.G. Smirnova, V.Yа. Melnichenko

  343-353

  01.07.2014

• Mantle cell lymphoma: program therapy for untreated patients under 65 years

  V.I. Vorobyev, S.K. Kravchenko, E.G. Gemdjian, Yu.Yu. Lorie, A.U. Magomedova, A.L. Melikyan, J.K. Mangasarova, D.S. Mar’yin, E.I. Dubrovin, T.N. Obukhova, S.A. Makhinya, V.A. Zherebtsova, M.A. Vernyuk, N.G. Tyurina, V.G. Savchenko

  274-281

  01.07.2013